BioCentury
ARTICLE | Financial News

Adaptimmune Therapeutics completes IPO

May 11, 2015 7:00 AM UTC

Adaptimmune Therapeutics plc (NASDAQ:ADAP), Abingdon, U.K. Business: Cancer, Infectious, Gene/Cell therapy Date completed: 2015-05-06 Type: IPO Raised: $191.3 million Shares: 11.3 million Price: $17 S...